Browsing Tag
VolitionRx Limited
2 posts
VolitionRx Limited faces NYSE compliance deadline tied to sustained sub-US$1 share price
VolitionRx Limited receives a NYSE non-compliance notice tied to its share price. Find out what it means for investors, strategy, and what comes next.
VolitionRx’s Nu.Q Cancer Test targets multi-billion-dollar liquid biopsy market
VolitionRx’s Nu.Q Cancer Test is transforming liquid biopsy diagnostics, offering a non-invasive, cost-effective blood test for early cancer detection.